Market Overview:
The global Bifida Ferment Lysate market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to the increasing demand for Bifida Ferment Lysate from various applications such as company and laboratory. North America is expected to dominate the global Bifida Ferment Lysate market during the forecast period owing to technological advancements and growing awareness about benefits of using Bifida Ferment Lysate products. Asia Pacific is projected to be fastest-growing region in terms of CAGR during the forecast period.
Product Definition:
Bifida Ferment Lysate is a probiotic that helps to support the skin's barrier function and defend against environmental stressors. It is also known for its ability to promote wound healing.
Liquid:
Liquid is a by-product obtained during the fermentation of sugarcane or corn. It contains a high concentration of beneficial lactic acid bacteria, which helps in improving gut health and reducing the risk for several diseases including cancer. The most commonly used liquid in biopharmaceutical applications is Bifidobacterium infantis, as it has been observed to be effective against several pathogenic microorganisms such as Salmonella typhi and E.
Cream:
Cream is a by-product formed during the fermentation of milk. It contains lactic acid bacteria and is used as an ingredient in the production of yogurt, butter, kefir cheese, and other dairy products. The product also has several applications in non-dairy beverages such as fruit juices & soft drinks which makes it one of the most important ingredients for bifidogenic purposes.
Application Insights:
The company application segment accounted for the largest share of over 60.0% in 2017. The product is used as a nutritional supplement and food ingredient for manufacturing various foods and beverages such as dairy products, bakery & confectionery, meat products, soy sauce, vinegar among others. Furthermore, it is also used in the production of biopharmaceuticals such as monoclonal antibodies that are employed for cancer treatment and other diseases such as diabetes & autoimmune disorders.
The laboratory application segment is expected to witness the fastest growth rate over the forecast period owing to increasing demand from research laboratories across the world who require these substrates at short notice when compared with other sources which may take longer time to deliver due to custom clearance procedures required during international transportation of lab-made materials hence resulting in an increased preference towards using this product from local suppliers thereby driving its demand globally.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. North America has a large number of biotechnology and pharmaceutical companies, which are majorly involved in drug discovery activities using bifida peptides as research tools. Thus, increasing demand for bifida peptide-based products from these companies is anticipated to drive the regional market over the forecast period.
Asia Pacific is expected to grow at a lucrative rate during the same period owing to increasing healthcare expenditure by governments and rising awareness about infant health among mothers in developing countries including China, India and Bangladesh. Moreover, growing medical tourism industry due to low cost of treatment & high availability of advanced healthcare services will also boost product demand over the next eight years (2018 - 2030).
Growth Factors:
- Increasing awareness about the benefits of Bifida Ferment Lysate is expected to drive the market growth.
- Rising demand for natural and organic products is anticipated to boost the market growth.
- Growing number of research studies on Bifida Ferment Lysate is projected to propel the market growth in near future.
- Increasing application areas of Bifida Ferment Lysate is likely to create new opportunities for the market players in coming years.
- Growing popularity of probiotics supplements is estimated to fuel the demand for Bifida Ferment Lysate over forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Bifida Ferment Lysate Market Research Report
By Type
Liquid, Cream
By Application
Company, Laboratory
By Companies
STARRISS, Huining Biotechnology, Danjoungbio, Yangzhou Joyvo Weikem Biology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Bifida Ferment Lysate Market Report Segments:
The global Bifida Ferment Lysate market is segmented on the basis of:
Types
Liquid, Cream
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Company, Laboratory
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- STARRISS
- Huining Biotechnology
- Danjoungbio
- Yangzhou Joyvo Weikem Biology
Highlights of The Bifida Ferment Lysate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Liquid
- Cream
- By Application:
- Company
- Laboratory
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bifida Ferment Lysate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bifida ferment lysate is a probiotic supplement that contains live cultures of Lactobacillus acidophilus and Bifidobacterium bb12. These bacteria are beneficial to the gut health because they help to break down food into nutrients that can be absorbed by the body.
Some of the major players in the bifida ferment lysate market are STARRISS, Huining Biotechnology, Danjoungbio, Yangzhou Joyvo Weikem Biology.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Bifida Ferment Lysate Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Bifida Ferment Lysate Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Bifida Ferment Lysate Market - Supply Chain
4.5. Global Bifida Ferment Lysate Market Forecast
4.5.1. Bifida Ferment Lysate Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Bifida Ferment Lysate Market Size (000 Units) and Y-o-Y Growth
4.5.3. Bifida Ferment Lysate Market Absolute $ Opportunity
5. Global Bifida Ferment Lysate Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Bifida Ferment Lysate Market Size and Volume Forecast by Type
5.3.1. Liquid
5.3.2. Cream
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Bifida Ferment Lysate Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Bifida Ferment Lysate Market Size and Volume Forecast by Application
6.3.1. Company
6.3.2. Laboratory
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Bifida Ferment Lysate Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Bifida Ferment Lysate Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Bifida Ferment Lysate Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Bifida Ferment Lysate Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Bifida Ferment Lysate Demand Share Forecast, 2019-2026
9. North America Bifida Ferment Lysate Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Bifida Ferment Lysate Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Bifida Ferment Lysate Market Size and Volume Forecast by Application
9.4.1. Company
9.4.2. Laboratory
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Bifida Ferment Lysate Market Size and Volume Forecast by Type
9.7.1. Liquid
9.7.2. Cream
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Bifida Ferment Lysate Demand Share Forecast, 2019-2026
10. Latin America Bifida Ferment Lysate Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Bifida Ferment Lysate Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Bifida Ferment Lysate Market Size and Volume Forecast by Application
10.4.1. Company
10.4.2. Laboratory
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Bifida Ferment Lysate Market Size and Volume Forecast by Type
10.7.1. Liquid
10.7.2. Cream
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Bifida Ferment Lysate Demand Share Forecast, 2019-2026
11. Europe Bifida Ferment Lysate Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Bifida Ferment Lysate Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Bifida Ferment Lysate Market Size and Volume Forecast by Application
11.4.1. Company
11.4.2. Laboratory
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Bifida Ferment Lysate Market Size and Volume Forecast by Type
11.7.1. Liquid
11.7.2. Cream
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Anlysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Bifida Ferment Lysate Demand Share, 2019-2026
12. Asia Pacific Bifida Ferment Lysate Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Bifida Ferment Lysate Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Bifida Ferment Lysate Market Size and Volume Forecast by Application
12.4.1. Company
12.4.2. Laboratory
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Bifida Ferment Lysate Market Size and Volume Forecast by Type
12.7.1. Liquid
12.7.2. Cream
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Bifida Ferment Lysate Demand Share, 2019-2026
13. Middle East & Africa Bifida Ferment Lysate Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Bifida Ferment Lysate Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Bifida Ferment Lysate Market Size and Volume Forecast by Application
13.4.1. Company
13.4.2. Laboratory
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Bifida Ferment Lysate Market Size and Volume Forecast by Type
13.7.1. Liquid
13.7.2. Cream
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Bifida Ferment Lysate Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Bifida Ferment Lysate Market: Market Share Analysis
14.2. Bifida Ferment Lysate Distributors and Customers
14.3. Bifida Ferment Lysate Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. STARRISS
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Huining Biotechnology
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Danjoungbio
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Yangzhou Joyvo Weikem Biology
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
